Emblem Corp

EMC

CA29082J1084

Pharmaceuticals

End-of-day quote Toronto S.E. Other stock markets 03:59:45 2019-03-18 pm EDT			5-day change	1st Jan Change
1.88 ^CAD	+1.62%		+1.62%	+106.59%

2019	Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
2019	Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index	CI

Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018

May 14, 2019 at 04:06 pm EDT

Emblem Corp. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CAD 8.223 million compared to CAD 2.694 million a year ago. Net loss was CAD 24.259 million compared to CAD 12.101 million a year ago. Basic loss per share was CAD 0.2 compared to CAD 0.14 a year ago.

Latest news about Emblem Corp

Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-05-14	CI
Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index	19-03-19	CI
Aleafia Health Inc. completed the acquisition of Emblem Corp..	19-03-13	CI
Emblem Corp. Announces Amended By-Laws; Announces Change to the Registered Office	19-03-06	CI
Transcript : Emblem Corp., Aleafia Health Inc. - M&A Call	18-12-19
Aleafia Health Inc. executed a letter of intent to acquire Emblem Corp. for approximately CAD 160 million.	18-12-18	CI
Emblem Corp Announces Executive Appointments	18-12-10	CI
Emblem Corp. Appoints Wayne Kreppner as Division President	18-11-20	CI
Emblem Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	18-11-20	CI
Emblem Corp. Announces Board Changes	18-11-07	CI
Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President	18-10-11	CI
10330698 Canada Ltd. announced that it has received CAD 1 million in funding from Emblem Corp.	18-09-29	CI
DriveABLE Assessment Centres Inc. announced that it has received funding from Emblem Corp.	18-09-23	CI
Emblem Corp. and Natura Naturals Holdings Inc. Announce Termination of Letter of Intent	18-09-14	CI
Natura Naturals Inc. cancelled the transaction announced on July 18, 2018	18-09-13	CI
Emblem Launches Atmosphere, Its First Oral Dose-Metered Spray	18-09-13	CI
Emblem Corp. cancelled the acquisition of remaining 93% stake in Natura Naturals Inc.	18-09-12	CI
Natura Naturals Inc. announced that it has received CAD 2 million in funding from Emblem Corp.	18-09-12	CI
Emblem Corp Enters into Five-Year Wholesale Supply Agreement with Aphria Inc	18-09-12	CI
10330698 Canada Ltd. announced that it expects to receive CAD 1 million in funding from Emblem Corp.	18-09-09	CI
Emblem Corp. Signs Five Year Supply Agreement with Compass Cannabis Clinic for Starbuds Canada	18-09-06	CI
Natura Naturals Inc. announced that it expects to receive CAD 2 million in funding from Emblem Corp.	18-08-22	CI
Emblem Corp. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2018	18-08-22	CI
GreenSpace Brands Inc. announced that it has received CAD 2 million in funding from Emblem Corp.	18-08-08	CI
Emblem Corp. and GreenSpace Brands Partner to Launch New CBD-Infused Health and Beauty Line	18-08-08	CI

Chart Emblem Corp

Duration

Period

More charts

Company Profile

Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Companyâs assets are located in Canada.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
EMBLEM CORP	+106.59%	0
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

Emblem Corp

Equities

EMC

CA29082J1084

Pharmaceuticals

Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018

Latest news about Emblem Corp

Chart Emblem Corp

Company Profile

Sector Alternative Medicine